NEW YORK, March 9 - Invitrogen has sold its Rockville, Md., facility to Human Genome Sciences for $55 million in cash, the company said Friday.

Invitrogen acquired the 240,000 square foot facility in its September 2000 acquisition of Life Technologies, which had it headquarters located at the facility. Invitrogen occupies facilities in five other locations, including a manufacturing site in Frederick County, Md.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.